Bionoid Pharma, Inc.

Bionoid Pharma, Inc.

BINP - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.62M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bionoid Pharma, Inc.Bionoid Pharma, Inc.-10.1--20%--
$-0.01

Current Fair Value

121% downside

Overvalued by 121% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.62 Million
Enterprise Value$1.64 Million
Earnings per Share$-0.01
Beta-4.66
Outstanding Shares53,994,610

Return

Return on Equity-19.60%ROE
Return on Assets-18.87%
Return on Invested Capital-4.52%

Valuation & Multiples

P/E Ratio-10.08P/E Ratio
PEG-0.17PEG
Price to Sales-0.03Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-164.32
Enterprise Value to EBIT-9.21
Enterprise Value to Net Income-3
Total Debt to Enterprise0.01
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Listed Funds Trust

5 employees
CEO: Wayne Douglas Cockburn

AI Maverick Intel, Inc., an AI company, focuses on acquiring and enhancing businesses through its proprietary AI Maverick platform. Its technology streamlines the customer acquisition process by automating two way communication and data-...